Detalhe da pesquisa
1.
Potential roles of gut microbiome and metabolites in modulating ALS in mice.
Nature
; 572(7770): 474-480, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31330533
2.
CD4 T-cell aging exacerbates neuroinflammation in a late-onset mouse model of amyotrophic lateral sclerosis.
J Neuroinflammation
; 21(1): 17, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38212835
3.
4-Phenylbutyric Acid (4-PBA) Derivatives Prevent SOD1 Amyloid Aggregation In Vitro with No Effect on Disease Progression in SOD1-ALS Mice.
Int J Mol Sci
; 23(16)2022 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36012668
4.
Early upregulation of cytosolic phospholipase A2α in motor neurons is induced by misfolded SOD1 in a mouse model of amyotrophic lateral sclerosis.
J Neuroinflammation
; 18(1): 274, 2021 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34823547
5.
Targeting low levels of MIF expression as a potential therapeutic strategy for ALS.
Cell Rep Med
; : 101546, 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38703766
6.
Therapeutic Potential of Phytocannabinoid Cannabigerol for Multiple Sclerosis: Modulation of Microglial Activation In Vitro and In Vivo.
Biomolecules
; 13(2)2023 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36830745
7.
All Roads Lead to Rome: Different Molecular Players Converge to Common Toxic Pathways in Neurodegeneration.
Cells
; 10(9)2021 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34572087